Guidelines

• Tuberculosis Screening, Testing, and Treatment of U.S. Health Care Personnel (6/2019)
• Frequently Asked Questions Regarding 2019 Health Care Personnel TB Screening Guidelines (6/2019)
• Update of Recommendations for Use of Once-Weekly Isoniazid-Rifapentine Regimen to Treat Latent Mycobacterium tuberculosis Infection (6/2018)
• Diagnosis of Tuberculosis in Children and Adults (1/2017)
• Treatment of Drug-Susceptible Tuberculosis (8/2016)
• Managing Drug Interactions in the Treatment of HIV-Related Tuberculosis (6/2013)
• Updated Guidelines for Using Interferon Gamma Release Assays to Detect Mycobacterium tuberculosis Infection (6/2010)
• Prevention and Control of Tuberculosis in Correctional and Detention Facilities: (7/2006)
• Guidelines for the Investigation of Contacts of Persons with Infectious Tuberculosis (12/2005)

Provider Resources

• Summary of Provider Guidelines for Latent Tuberculosis Testing and Treatment (CDC)
• Latent Tuberculosis Infection: A Guide for Primary Care Providers (CDC)
• Guide to Using Isoniazid/Rifapentine to Treat Latent Tuberculosis Infection (NTCA)

Screening Among Healthcare Personnel

• Dear Colleague Letter: 2019 NTCA/CDC Healthcare Personnel TB Guideline Changes (6/2019)
• Presentation for Infection Control Professionals on Updated 2019 Guidelines for Health Care Personnel Screening (6/2019)
• Pre-Placement TB Screening for Healthcare Personnel Sample Form with Algorithm [PDF]  (6/2019)
• Pre-Placement TB Screening for Healthcare Personnel Sample Form with Algorithm [DOC]  (6/2019)